CVRdatabase
Menu

de novo foundry ApS

Private limited companyCVR 38734164FrederiksbergActive

de novo foundry ApS is a private limited company, based in Frederiksberg, active in other professional, scientific and technical activities n.e.c., founded in 2017. The company made a loss in both 2024 and 2025, most recently DKK 11.5m. With 11 employees, the company is about 6 times larger than the industry median. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 4.6m−47.2% vs. 2024
Net profit−DKK 11.5m−63.2% vs. 2024
EquityDKK 16.7m−8.2% vs. 2024
Employees11latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 47% (2024 → 2025), to DKK 4.6m.
  • The loss grew: from DKK 7m to DKK 11.5m (2024 → 2025).
  • Equity fell 8% (2024 → 2025), to DKK 16.7m.

Employees

  • 6 fewer employees than a year earlier: 11 (07/2026) against 17 (07/2025).

Management and owners, last 24 months

  • New in management: João Carlos Ribas de Almeida (chair of the board, 01/07/2025), Gabor Gyulveszi (board member, 01/07/2025) and Thomas Gundelund Rasmussen (ceo, 01/09/2025) (+1).
  • Stepped down: Emmanuelle Coutanceau (chair of the board, 30/06/2025), Morten Døssing (board member, 01/02/2025) and Søren Sylvester Skjærbæk (ceo, 31/08/2025) (+1).

Registrations, last 24 months

  • 01/07/2025: Name changed from BiOrigin ApS to de novo foundry ApS
  • 05/02/2025: Share capital changed from 500,009 DKK to 500,010 DKK
  • 17/12/2024: Moved to Nordre Fasanvej 215, 2000 Frederiksberg
  • 18/11/2024: Share capital changed from 500,008 DKK to 500,009 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 15m−DKK 10m−DKK 5mDKK 0DKK 5mDKK 10mDKK 15mDKK 20m202020212022202320242025
EquityNet profit
Financial figures for de novo foundry ApS
202020212022202320242025Change
Revenue1,6522,0275,849not statednot statednot stated–
Gross profit1,0691259792,8768,6954,592−47.2%
Operating profit (EBIT)−3,993−3,567−7,703−14,610−9,429−15,013−59.2%
Profit before tax−3,986−3,627−7,713−14,452−9,080−14,765−62.6%
Net profit−3,109−2,830−6,018−11,228−7,045−11,500−63.2%
Total assets10,9607,76913,54014,61422,79423,079+1.3%
Equity9,3366,50610,48810,26018,21516,714−8.2%
Liabilities1,6251,2633,0114,2934,5206,365+40.8%
Cash and cash equivalents9,0016,6469,3947,32614,02413,644−2.7%
Average number of employees436131412−14.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 2mDKK 4mDKK 6mDKK 8m202020212022202320242025
Gross profitMedian, the industry (310 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for de novo foundry ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202522/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202404/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202305/04/2024The companyPDFXBRL
202201/01/2022 – 31/12/202208/05/2023The companyPDFXBRL
202101/01/2021 – 31/12/202123/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202008/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0510152008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

310 companies in the database

Comparison with the other companies in other professional, scientific and technical activities n.e.c. based on the latest financial year.

Gross profitDKK 4.6mNo. 96 of 309
Better than 69% of the companies in the industry
EquityDKK 16.7mNo. 22 of 310
Better than 93% of the companies in the industry
Number of employees11No. 41 of 310
Better than 87% of the companies in the industry

Industry median: gross profit DKK 1.9m, net profit DKK 142k, equity DKK 1.1m, 2 employees.

DKK 100kDKK 708kDKK 5mDKK 35.5mDKK 130.8mHere
Distribution of gross profit for 278 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 14,775of 69,742
Better than 79%
No. 6,515of 69,964
Better than 91%
Same industry and fewer than 20 employees281 companies in the comparison
No. 69of 281
Better than 76%
No. 15of 281
Better than 95%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 9,299of 33,588
Better than 72%
No. 2,631of 33,687
Better than 92%
All companies of type ApS66,508 companies in the comparison
No. 15,022of 66,379
Better than 77%
No. 4,797of 66,505
Better than 93%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Other professional, scientific and technical activities n.e.c.
Gross profit
  1. de novo foundry ApSDKK 4.6m
  2. Clearwater Denmark K/SDKK 251.1m
  3. Bureau Veritas Denmark A/SDKK 149.1m
Net profit
  1. de novo foundry ApS−DKK 11.5m
  2. Clearwater Denmark K/SDKK 134.2m
  3. Bureau Veritas Denmark A/SDKK 17.3m
Equity
  1. de novo foundry ApSDKK 16.7m
  2. Clearwater Denmark K/SDKK 76.4m
  3. Bureau Veritas Denmark A/SDKK 18.7m
Employees
  1. de novo foundry ApS11
  2. Clearwater Denmark K/S56
  3. Bureau Veritas Denmark A/S161

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
de novo foundry ApS

Management

3 active registrations

Executive management

Executive management at de novo foundry ApS
NameRoleAppointed
Thomas Gundelund RasmussenCEO01/09/2025

Board of directors

Board of directors at de novo foundry ApS
NameRoleAppointed
João Carlos Ribas de AlmeidaChair of the board01/07/2025
Gabor GyulvesziBoard member01/07/2025
Founders
Novo Holdings A/S
Former management (8)
Former management at de novo foundry ApS
NameRoleAppointedResigned
Jakob Dynnes HansenCEO22/06/201701/12/2022
Stephan ChristgauChair of the board22/06/201716/09/2019
Emmanuelle CoutanceauBoard member22/06/201715/09/2019
Emmanuelle CoutanceauChair of the board16/09/201930/06/2025
Pieter Jeroen BakkerBoard member16/09/201930/08/2024
Morten DøssingBoard member22/06/202201/02/2025
Søren Sylvester SkjærbækCEO01/12/202231/08/2025
João Carlos Ribas de AlmeidaBoard member01/02/202530/06/2025

Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem og en direktør i forening eller af den samlede bestyrelse.

Address and production units

2 active production units

Nordre Fasanvej 215
2000 Frederiksberg

Frederiksberg Municipality · Postcode 2000

Other companies at the address (8)

  • Sparrow Quantum ApSManufacture of computers and peripheral equipment
  • Adcendo ApSResearch and experimental development on natural sciences and engineering
  • Hemab ApSManufacture of pharmaceutical preparations
  • Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
  • Minervax ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
de novo foundry ApSNordre Fasanvej 215, 2000 Frederiksberg81022557013
Seed LabsOle Maaløes Vej 5, 2200 København N21030921360

Purpose

Selskabets formål er at drive virksomhed med ydelse af konsulentbistand og rådgivning i forbindelse med investering i og drift af selskaber der arbejder med udvikling af lægemidler, medicinsk udstyr eller diagnostiske metode eller anden beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

39 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
202511 changesmanagement 8 · name 1 · accounts 1 · capital 1
  • Thomas Gundelund Rasmussen appointed ceo
  • Søren Sylvester Skjærbæk stepped down as ceo
  • Name changed from BiOrigin ApS to de novo foundry ApS
  • Gabor Gyulveszi appointed board member
  • João Carlos Ribas de Almeida appointed chair of the board
  • João Carlos Ribas de Almeida stepped down as board member
  • Emmanuelle Coutanceau stepped down as chair of the board
  • Annual report for 2024 published
  • Share capital changed from 500,009 DKK to 500,010 DKK
  • João Carlos Ribas de Almeida appointed board member
  • Morten Døssing stepped down as board member
20245 changesaddress 1 · capital 2 · management 1 · accounts 1
  • Moved to Nordre Fasanvej 215, 2000 Frederiksberg
  • Share capital changed from 500,008 DKK to 500,009 DKK
  • Pieter Jeroen Bakker stepped down as board member
  • Annual report for 2023 published
  • Share capital changed from 500,006 DKK to 500,008 DKK
20233 changescapital 2 · accounts 1
  • Share capital changed from 500,005 DKK to 500,006 DKK
  • Annual report for 2022 published
  • Share capital changed from 500,004 DKK to 500,005 DKK
20225 changesmanagement 3 · capital 1 · accounts 1
  • Søren Sylvester Skjærbæk appointed ceo
  • Jakob Dynnes Hansen stepped down as ceo
  • Share capital changed from 500,003 DKK to 500,004 DKK
  • Annual report for 2021 published
  • Morten Døssing appointed board member
20211 changeaccounts 1
  • Annual report for 2020 published
20201 changecapital 1
  • Share capital changed from 500,002 DKK to 500,003 DKK
20195 changescapital 1 · management 4
  • Share capital changed from 500,001 DKK to 500,002 DKK
  • Pieter Jeroen Bakker appointed board member
  • Emmanuelle Coutanceau appointed chair of the board
  • Stephan Christgau stepped down as chair of the board
  • Emmanuelle Coutanceau stepped down as board member
20181 changecapital 1
  • Share capital changed from 500,000 DKK to 500,001 DKK
20176 changesname 1 · founded 1 · management 3 · ownership 1
  • Name changed from Bio Origin ApS to BiOrigin ApS
  • Registered as Bio Origin ApS
  • Jakob Dynnes Hansen appointed ceo
  • Emmanuelle Coutanceau appointed board member
  • Stephan Christgau appointed chair of the board
  • Novo Holdings A/S registered as owner (100%)

Related companies

Same industry in Frederiksberg

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction